
Available Now
MARK-B™ COVID-19 Antigen Test
Simple . Accurate . Fast .
The MARK-B™ COVID-19 Ag test is a electrochemical sandwich immunoassay that is used with the MARK-B™ 1 analyzer intended for the qualitative detection of the nucleocapsid protein antigen from SARS-CoV-2 in nasopharyngeal swab specimens.


34mm
34mm
*The MARK-B™ 1 analyzer(MB-100) and the MARK-B™ COVID-19 Ag are CE marked.
Benefits : COVID-19 antigen test
Deliver lab-quality results in 15 mins.
Test results in 15 minutes
Fast diagnosis with results in 15 minutes in various locations such as clinical laboratories, hospitals etc.
Turn-around Time
Sensitivity 94.4%
specificity 100.0%
The clinical performance of MARK-B™ COVID-19 Ag was established with a study using NPS specimens, which have been previously characterized and were supplied by a biorepository in the United States. In the clinical performance, seventy-two (72) samples were measured, resulting in a sensitivity of 94.4% (34/36) and a specificity of 100.0% (36/36).
Enable the physician to verify infection quickly, begin proper treatment and to initiate isolation precautions helping prevent further spread of infection.

Accuracy
Limit of Detection
2.39 x 10 TCID /mL
1
50
Detect a positive result against the low concentration sample without amplification before any symptom onset.

*The MARK-B™ COVID-19 Ag test cartridge. It's disposable.
Specification
-
Direct sample types include: Nasopharyngeal swabs
-
Simple operation via visual touchscreen
-
Assay kit contains all necessary components for testing to include: 25 test cartridges, swabs for sample collection, reagent solution kits
-
Actionable results in 15 minutes or less
Benefits : MARK-B™ 1 analyzer
Every infectious disease test needs quick answers. That’s why you need MARK-B™ 1 analyzer; a high-performance immunoassay analyzer that provides accurate results in minutes, not hours.
-
Easy to learn and use only minimal training requirements
-
Small footprint saves you bench space
-
Can be used in any healthcare setting
-
Large visual touchscreen displays results
-
Eliminating transcription errors and the need for printing
-
No need for calibration
-
Facilitates effective patient management
*The MARK-B™ 1 analyzer(MB-100) is CE marked.

